The Market Reports

Synopsis
The global market for Colistin Sulphate was estimated to be worth US$ 60.8 million in 2024 and is forecast to a readjusted size of US$ 49.9 million by 2031 with a CAGR of -2.5% during the forecast period 2025-2031.
Colistin, also known as polymyxin E, is an antibiotic produced by certain strains of the bacteria Paenibacillus polymyxa. Colistin is a mixture of the cyclic polypeptides colistin A and B and belongs to the class of polypeptide antibiotics known as polymyxins. Colistin is effective against most Gram-negative bacilli.
Market Driver: The Colistin Sulphate market is driven by the rising prevalence of multidrug-resistant (MDR) bacterial infections, particularly those caused by Gram-negative pathogens such as Pseudomonas aeruginosa and Acinetobacter baumannii. As antibiotic resistance becomes a global health crisis, Colistin Sulphate remains one of the few effective treatment options for severe MDR infections. Additionally, its extensive use in veterinary medicine for disease prevention and treatment in livestock, especially in poultry and swine, further supports market growth. The increasing demand for livestock production to meet global food supply needs also drives the demand for Colistin Sulphate in animal husbandry.
Market Challenge: Despite its demand, the Colistin Sulphate market faces challenges due to growing concerns over antimicrobial resistance (AMR) and regulatory restrictions. Many countries have implemented strict regulations to limit its use in agriculture, particularly as a growth promoter, to combat the rise of antibiotic-resistant bacteria. In human medicine, the potential nephrotoxicity and neurotoxicity of Colistin Sulphate pose safety concerns, leading to cautious use and the development of alternative treatments. Additionally, the emergence of colistin-resistant bacterial strains further threatens the long-term viability of the drug, prompting research into novel antimicrobial agents and alternative therapeutic strategies.
Global Colistin Sulphate key players include Shengxue Dacheng , Apeloa, LKPC, Xellia, Shenghua Biok, etc. Global top five manufacturers hold a share about 55%. China is the largest market, with a share over 75%, followed by Japan and Europe, both have a share over 10 percent. In terms of product, Colistin Sulphate API is the largest segment, with a share over 90%. And in terms of application, the largest application is Chicken Colistin Sulphate, followed by Pig Colistin Sulphate.
This report aims to provide a comprehensive presentation of the global market for Colistin Sulphate, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Colistin Sulphate by region & country, by Type, and by Application.
The Colistin Sulphate market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colistin Sulphate.
Market Segmentation
By Company
Shengxue Dacheng
Apeloa
Livzon Group
LKPC
Xellia
Shenghua Biok
Qianjiang Biochemical
Lifecome
Segment by Type
Colistin Sulphate API
Colistin Sulphate Premix
Segment by Application
Pig
Chicken
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Colistin Sulphate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Colistin Sulphate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Colistin Sulphate in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index